围发作期MRI异常与癫痫持续状态患者死亡率、抗癫痫药物难治性及致残率的关联
该回顾性观察性队列研究纳入法国波尔多大学医院2015年1月至2019年12月收治的307例癫痫持续状态患者,其中79例(26%)存在围发作期MRI异常。围发作期MRI异常组院内死亡率显著高于无异常组(27% vs 11%,p<0.001),且与难治性癫痫持续状态及幸存者迟发性癫痫风险升高相关。
要点
- 围发作期MRI异常见于26%(79/307)的癫痫持续状态患者。
- 围发作期MRI异常组院内死亡率为27%(21/79),无异常组为11%(24/228),差异有统计学意义(p<0.001)。
- 围发作期MRI异常与难治性癫痫持续状态(71% vs 33%,p<0.001)及幸存者迟发性癫痫(40% vs 21%,p=0.009)相关。
核心结论
- 在迄今评估围发作期MRI异常对癫痫持续状态预后价值的最大队列中,围发作期MRI异常阳性患者死亡率更高。
- 围发作期MRI异常作为一种无创且易于获取的工具,是用于癫痫持续状态患者个体化预后评估的有前景的结构性生物标志物。
研究设计与样本
- 回顾性观察性队列研究,纳入法国波尔多大学医院2015年1月至2019年12月收治的年龄超过15岁、连续住院的癫痫持续状态患者,共307例。
- 主要终点为院内死亡率;进行了专门的神经影像学再评估及综合医学回顾,评估基线特征、院内死亡、癫痫持续状态特征、药物难治性及幸存者后续结局。
主要发现
- 307例患者中79例(26%)存在与癫痫持续状态相关的围发作期MRI异常。
- 围发作期MRI异常阳性组与阴性组在人口学特征、基线功能状态及癫痫持续状态发作至MRI检查的中位延迟时间方面相似。
- 院内死亡发生于15%(45/307)的患者,围发作期MRI异常阳性组(27%,21/79)显著高于阴性组(11%,24/228),p<0.001。
- 多变量分析中,围发作期MRI异常(OR 2.86,95%CI 1.02-8.18;p=0.045)、癫痫持续状态持续时间(OR 1.01,95%CI 1.01-1.02;p=0.007)、癫痫持续状态发病年龄较大(OR 1.05,95%CI 1.01-1.09;p=0.013)、既存最终致死性合并症(OR 4.01,95%CI 1.56-10.6;p=0.004)及急性病变性癫痫持续状态病因(OR 3.74,95%CI 1.45-10.2;p=0.007)为院内死亡的独立预测因素。
- 围发作期MRI异常阳性组难治性癫痫持续状态风险更高(71% vs 33%,p<0.001);幸存者中迟发性癫痫更常见(40% vs 21%,p=0.009)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Status epilepticus (SE) is a life-threatening emergency requiring a prompt assessment of patient prognosis to guide management. MRI allows the identification of peri-ictal MRI abnormalities (PMAs) and provides insight into brain structural modifications induced by SE. However, little is known about the significance of PMA in SE prognosis. The aim of this study was to determine whether PMAs are associated with an increased mortality in SE and to establish the association between PMA and refractoriness to antiseizure medications, complications encountered, and induced morbidity. METHODS: We conducted a retrospective observational cohort study including all eligible consecutive patients over 15 years old and hospitalized with SE at Bordeaux University Hospital (France) between January 2015 and December 2019. The primary end point was in-hospital mortality. A dedicated neuroradiologic reassessment was performed, together with a comprehensive medical review assessing baseline characteristics, in-hospital death, SE characterization, drug refractoriness, and following outcome in survivors. RESULTS: Of 307 patients included, 79 (26%) showed PMA related to SE. Demographic, functional status at baseline and median delay between SE onset and MRI examination were similar in the PMA-positive and PMA-negative groups. In-hospital death occurred in 15% (45/307) patients and was significantly higher in the PMA-positive group (27%, 21/79 vs 11%, 24/228; p < 0.001). In multivariate analysis, the presence of PMA (odds ratio [OR] 2.86, 95% CI 1.02-8.18; p = 0.045), together with SE duration (OR 1.01, 95% CI 1.01-1.02; p = 0.007), older age at SE onset (OR 1.05, 95% CI 1.01-1.09; p = 0.013), preexisting ultimately fatal comorbidity (OR 4.01, 95% CI 1.56-10.6; p = 0.004), and acute lesional SE etiology (OR 3.74, 95% CI 1.45-10.2; p = 0.007) were independent predictors associated with in-hospital death. Patients with PMA had a higher risk of refractory SE (71 vs 33%, p < 0.001). Among survivors, delayed-onset epilepsy (40% vs 21%, p = 0.009) occurred more frequently in the PMA-positive group. DISCUSSION: PMA-positive cases had a higher mortality rate in the largest cohort so far to assess the prognosis value of PMA in SE. As a noninvasive and easily available tool, PMA represents a promising structural biomarker for developing a personalized approach to prognostication in patients with SE receiving MRI.
引用
- Bonduelle T, Ollivier M, Trin K, et al. Association of Peri-ictal MRI Abnormalities With Mortality, Antiseizure Medication Refractoriness, and Morbidity in Status Epilepticus. Neurology. 2022. PMID: 36443013. doi:10.1212/WNL.0000000000201599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。